Search

Hai V Tran

Examiner (ID: 9064, Phone: (571)270-7650 , Office: P/2845 )

Most Active Art Unit
2845
Art Unit(s)
2611, 2845, 2426, 4100, 2711, 2623, 2423, 2491, 2821
Total Applications
1291
Issued Applications
923
Pending Applications
111
Abandoned Applications
257

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17163174 [patent_doc_number] => 11149263 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-10-19 [patent_title] => Method for purifying and quantifying thrombin and its degradation polypeptides [patent_app_type] => utility [patent_app_number] => 16/712207 [patent_app_country] => US [patent_app_date] => 2019-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 19926 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16712207 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/712207
Method for purifying and quantifying thrombin and its degradation polypeptides Dec 11, 2019 Issued
Array ( [id] => 17665307 [patent_doc_number] => 11358988 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-14 [patent_title] => Immunomodulators [patent_app_type] => utility [patent_app_number] => 16/711105 [patent_app_country] => US [patent_app_date] => 2019-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 124117 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16711105 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/711105
Immunomodulators Dec 10, 2019 Issued
Array ( [id] => 17383947 [patent_doc_number] => 20220031799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => METHODS AND COMPOSITIONS FOR THE TREATMENT OF SENGERS SYNDROME [patent_app_type] => utility [patent_app_number] => 17/299681 [patent_app_country] => US [patent_app_date] => 2019-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14231 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299681 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/299681
Methods and compositions for the treatment of Sengers syndrome Dec 4, 2019 Issued
Array ( [id] => 15895337 [patent_doc_number] => 20200147187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-14 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING NEONATAL BILIARY ATRESIA [patent_app_type] => utility [patent_app_number] => 16/703939 [patent_app_country] => US [patent_app_date] => 2019-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4782 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16703939 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/703939
Compositions and methods for treating neonatal biliary atresia Dec 4, 2019 Issued
Array ( [id] => 17428369 [patent_doc_number] => 20220056077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => DUAL AGONIST GLP-1 AND NEUROTENSIN FUSION PEPTIDE [patent_app_type] => utility [patent_app_number] => 17/420110 [patent_app_country] => US [patent_app_date] => 2019-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10134 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17420110 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/420110
DUAL AGONIST GLP-1 AND NEUROTENSIN FUSION PEPTIDE Dec 3, 2019 Pending
Array ( [id] => 17266318 [patent_doc_number] => 11191722 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-07 [patent_title] => Treatment of diabetes mellitus by long-acting formulations of insulins [patent_app_type] => utility [patent_app_number] => 16/700541 [patent_app_country] => US [patent_app_date] => 2019-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 40189 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16700541 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/700541
Treatment of diabetes mellitus by long-acting formulations of insulins Dec 1, 2019 Issued
Array ( [id] => 17625809 [patent_doc_number] => 20220160824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => COMPOUNDS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE [patent_app_type] => utility [patent_app_number] => 17/298415 [patent_app_country] => US [patent_app_date] => 2019-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13750 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17298415 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/298415
COMPOUNDS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE Nov 27, 2019 Pending
Array ( [id] => 17292189 [patent_doc_number] => 20210388028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-16 [patent_title] => GLYCOPEPTIDE DERIVATIVE COMPOUNDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/295370 [patent_app_country] => US [patent_app_date] => 2019-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20554 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295370 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/295370
GLYCOPEPTIDE DERIVATIVE COMPOUNDS AND USES THEREOF Nov 19, 2019 Abandoned
Array ( [id] => 17342172 [patent_doc_number] => 20220008503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => MATERIALS AND METHODS FOR THE PREVENTION OF RHEUMATOID ARTHRITIS [patent_app_type] => utility [patent_app_number] => 17/294091 [patent_app_country] => US [patent_app_date] => 2019-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11384 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17294091 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/294091
MATERIALS AND METHODS FOR THE PREVENTION OF RHEUMATOID ARTHRITIS Nov 14, 2019 Pending
Array ( [id] => 15990521 [patent_doc_number] => 20200171131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-04 [patent_title] => FIBROIN-DERIVED PROTEIN COMPOSITION [patent_app_type] => utility [patent_app_number] => 16/680186 [patent_app_country] => US [patent_app_date] => 2019-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14510 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16680186 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/680186
Fibroin-derived protein composition Nov 10, 2019 Issued
Array ( [id] => 17775020 [patent_doc_number] => 20220241369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-04 [patent_title] => COMPOSITIONS AND METHODS OF MODULATING INFLAMMATION [patent_app_type] => utility [patent_app_number] => 17/292639 [patent_app_country] => US [patent_app_date] => 2019-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49038 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292639 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/292639
COMPOSITIONS AND METHODS OF MODULATING INFLAMMATION Nov 10, 2019 Pending
Array ( [id] => 17336012 [patent_doc_number] => 20220002343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-06 [patent_title] => PEPTIDE FRAGMENTS FOR TREATMENT OF DIABETES [patent_app_type] => utility [patent_app_number] => 17/289408 [patent_app_country] => US [patent_app_date] => 2019-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17021 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17289408 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/289408
PEPTIDE FRAGMENTS FOR TREATMENT OF DIABETES Nov 6, 2019 Pending
Array ( [id] => 17290979 [patent_doc_number] => 20210386818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-16 [patent_title] => COMPOSITIONS AND METHODS FOR THE PRODUCTION OF CYSTEINE [patent_app_type] => utility [patent_app_number] => 17/291812 [patent_app_country] => US [patent_app_date] => 2019-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14263 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291812 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/291812
COMPOSITIONS AND METHODS FOR THE PRODUCTION OF CYSTEINE Nov 5, 2019 Pending
Array ( [id] => 17312889 [patent_doc_number] => 20210401937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => COMPOSITION AND METHOD FOR ARTHRITIS [patent_app_type] => utility [patent_app_number] => 17/289664 [patent_app_country] => US [patent_app_date] => 2019-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21658 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17289664 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/289664
COMPOSITION AND METHOD FOR ARTHRITIS Oct 30, 2019 Pending
Array ( [id] => 16406740 [patent_doc_number] => 10815283 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-10-27 [patent_title] => Peptides for treatment of diabetes [patent_app_type] => utility [patent_app_number] => 16/666960 [patent_app_country] => US [patent_app_date] => 2019-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 12 [patent_no_of_words] => 14412 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16666960 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/666960
Peptides for treatment of diabetes Oct 28, 2019 Issued
Array ( [id] => 19181066 [patent_doc_number] => 11987648 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-21 [patent_title] => Cyclohexapeptides as selective somatostatin SST5 receptor agonists [patent_app_type] => utility [patent_app_number] => 17/284399 [patent_app_country] => US [patent_app_date] => 2019-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18334 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 273 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17284399 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/284399
Cyclohexapeptides as selective somatostatin SST5 receptor agonists Oct 13, 2019 Issued
Array ( [id] => 17519301 [patent_doc_number] => 20220105149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => WS-635 USES THEREOF IN MEDICINE [patent_app_type] => utility [patent_app_number] => 17/429667 [patent_app_country] => US [patent_app_date] => 2019-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9392 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17429667 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/429667
WS-635 USES THEREOF IN MEDICINE Oct 10, 2019 Pending
Array ( [id] => 15451331 [patent_doc_number] => 20200038489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-06 [patent_title] => Novel Use of Von Willebrand Factor [patent_app_type] => utility [patent_app_number] => 16/598373 [patent_app_country] => US [patent_app_date] => 2019-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7538 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16598373 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/598373
Novel Use of Von Willebrand Factor Oct 9, 2019 Abandoned
Array ( [id] => 15454415 [patent_doc_number] => 20200040032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-06 [patent_title] => PEPTIDE MACROCYCLES AND USE THEREOF IN THE TREATMENT OF BACTERIAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 16/596243 [patent_app_country] => US [patent_app_date] => 2019-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14314 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16596243 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/596243
Peptide macrocycles and use thereof in the treatment of bacterial infections Oct 7, 2019 Issued
Array ( [id] => 16428235 [patent_doc_number] => 10828296 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-10 [patent_title] => Treatment of T-cell mediated diseases [patent_app_type] => utility [patent_app_number] => 16/591322 [patent_app_country] => US [patent_app_date] => 2019-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9267 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16591322 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/591322
Treatment of T-cell mediated diseases Oct 1, 2019 Issued
Menu